BioMarin Reports Second Quarter 2026 Financial and Operating Results
Go back to BioMarin Reports Second Quarter 2026 Financial and Operating Results| BioMarin Pharmaceuticals, Inc. (NASDAQ: BMRN) | Delayed: 63.81 +2.35 (3.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $61.46 | 52 Week High | $108.96 | |||
| Open | $64.82 | 52 Week Low | $62.12 | |||
| Day High | $64.92 | P/E | N/A | |||
| Day Low | $62.20 | EPS | $-1.27 | |||
| Volume | 4,365,210 | |||||
